Table 2.

Univariate Proportional Hazards of Graft Failure

Predictor	HR (95%CI)	P value
Recipient
HOUSES (Single Ordinal Variable)	0.72 (0.52–0.99)	0.041
HOUSES (Q1 vs Q2–4)
Q1	Reference
Q2–Q4	0.55 (0.25– 1.22)	0.021
Age	0.99 (0.97–1.01)	0.37
Sex
Male	Reference
Female	0.96 (0.51–1.82)	0.90
Race
White-Caucasian	Reference
Non-White Caucasian	1.03 (0.45– 2.34)	0.95
Educational Attainment
No High School	Reference
High School	0.68 (0.19–2.48)	0.56
Some College	0.88 (0.26–3.01)	0.84
College	0.51 (0.12– 2.16)	0.36
Graduate or Higher	0.32 (0.07–1.45)	0.14
Associate Degree (% Per Census Block)
Q1	Reference
Q2–Q4	0.80 (0.41–1.57)	0.52
Income (% Per Census Block)
Q1	Reference
Q2–Q4	0.55 (0.29–1.03)	0.063
BMI	1.00 (0.98–1.03)	0.70
Previous Kidney Transplant	4.27 (2.19–8.30)	<.0001
Early Rejection	1.37 (0.49–3.85)	0.55
Dialysis Duration (months)
Preemptive	Reference
>0–6	1.22 (0.48– 3.11)	0.67
>6–12	2.10 (0.83 −5.34)	0.12
>12–18	1.30 (0.35– 4.81)	0.69
>18	1.72 (0.73– 4.06)	0.22
ESRD Etiology
Diabetes	Reference
Hypertension	0.92 (0.25 −3.36)	0.90
Cystic/Hereditary	0.27 (0.06 −1.24)	0.092
Other	0.79 (0.38–1.66)	0.54
HLA Mismatch	1.00 (0.76–1.33)	0.98
Delayed Graft	1.62 (0.58 −4.56)	0.36
Induction
Thymoglobulin	Reference
Campath	0	0.99
Other	0.79 (0.33–1.93)	0.61
Immunosuppression
Tacrolimus-based	Reference
Cyclosporine-based	2.17 (0.842 −5.593)	0.11
Other	1.50 (0.458–4.937)	0.50
Calcineurin Inhibitor	0.49 (0.17– 1.38)	0.17
CMV
R−/D−	Reference
R+/D+	0.60 (0.18–1.98)	0.40
R+/D−	1.29 (0.43–3.86)	0.65
R−/D+	0.91 (0.25–3.27)	0.88
Donor
Type (Deceased)	1.46 (0.78 −2.73)	0.24
Age	1.05 (0.99– 1.12)	0.09
Relationship to Donor (Unrelated)	1.48 (0.62– 3.54)	0.38

Q=Quartile